- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: EGFR tyrosine kinase inhibitor (EGFR TKI)
Total 69328 results
-
University of Colorado, DenverJanssen Research & Development, LLCRecruitingLung Cancer | Non Small Cell Lung CancerUnited States
-
Shanghai Pulmonary Hospital, Shanghai, ChinaUnknownNon-Small-Cell Lung Cancer
-
Ocular Therapeutix, Inc.CompletedNeovascular Age-Related Macular DegenerationUnited States
-
Shanghai Chest HospitalCompletedLung Adenocarcinoma | EGFR Activating Mutation
-
Washington University School of MedicineTerminatedCarcinoma, Non-Small-Cell Lung | Non-Small Cell Lung Cancer | Nonsmall Cell Lung CancerUnited States
-
Milton S. Hershey Medical CenterTerminatedChronic Myeloid Leukemia, Chronic PhaseUnited States
-
Jiangsu Hansoh Pharmaceutical Co., Ltd.Not yet recruiting
-
Ocular Therapeutix, Inc.Active, not recruitingNeovascular Age-related Macular DegenerationAustralia
-
Tracon Pharmaceuticals Inc.Completed
-
Cancer Institute and Hospital, Chinese Academy...Not yet recruitingNon Small Cell Lung Cancer | ERBB2 Mutation-Related Tumors | Disitamab Vedotin | ERBB2 Gene Duplication
-
AEterna ZentarisDana-Farber Cancer InstituteCompletedRenal Cell CarcinomaUnited States
-
AstraZenecaCompletedLocally Advanced or Metastatic EGFR Mutated NSCLC.Taiwan
-
Nanfang Hospital of Southern Medical UniversityUnknown
-
Gene SolutionsRecruitingNon Small Cell Lung Cancer | Stage IIIB Non-small Cell Lung Cancer | Stage IV Non-small Cell Lung Cancer | Stage IIIC Non-Small Cell Lung Cancer | Tyrosine Kinase InhibitorsVietnam
-
Hangzhou ACEA Pharmaceutical Research Co., Ltd.Cancer Institute and Hospital, Chinese Academy of Medical SciencesWithdrawn
-
Groupe Français de Pneumo-CancérologieCompletedNSCLC Non Small Cells Lung CancerFrance
-
Medical College of WisconsinH. Jean Khoury Cure CML ConsortiumRecruitingChronic Phase Chronic Myelogenous LeukemiaUnited States
-
The Affiliated Nanjing Drum Tower Hospital of Nanjing...RecruitingNon-clear Renal Cell CarcinomaChina
-
GlaxoSmithKlineCompleted
-
AstraZenecaActive, not recruitingStage IB-IIIA Non-small Cell Lung CarcinomaUnited States, Italy, Netherlands, Belgium, Canada, Poland, Romania, Taiwan, Thailand, Vietnam, France, Brazil, Hungary, Japan, Russian Federation, Turkey, China, Korea, Republic of, Germany, Hong Kong, Spain, Australia, Israel, Ukraine, Swed...
-
Fondazione IRCCS Istituto Nazionale dei Tumori,...Terminated
-
Sun Yat-sen UniversityRecruitingLiver Diseases | Hepatocellular Carcinoma | Immunotherapy | Sintilimab | LenvatinibChina
-
Bristol-Myers SquibbNektar TherapeuticsCompletedRenal Cell CarcinomaUnited States, Argentina, Brazil, Canada, France, Germany, Mexico, Russian Federation
-
Kura Oncology, Inc.Mirati Therapeutics Inc.RecruitingNon Small Cell Lung Cancer (NSCLC) | Pancreatic Ductal Adenocarcinoma (PDAC) | Colorectal Cancer (CRC) | Clear Cell Renal Cell Carcinoma (ccRCC) | Solid Tumors With HRAS AlterationsUnited States
-
Novartis PharmaceuticalsTerminatedNon-Small Cell Lung CancerItaly, Singapore, Spain, Germany, Korea, Republic of, United States, Belgium, France, Netherlands, Japan
-
Zhejiang Cancer HospitalUnknown
-
Samsung Medical CenterUnknownCarcinoma, Non-Small-Cell LungKorea, Republic of
-
University Health Network, TorontoBayer; AstraZeneca; Amgen; AnHeart Therapeutics Inc.; Applied Health Research Centre and other collaboratorsRecruitingCancer | Malignancies Multiple | Malignant Solid Tumor | Cancer, Therapy-Related | Molecular Sequence Variation | Genetic Alteration | Gene Fusion | Receptor Tyrosine Kinase Gene Mutation | RTK Family Gene Mutation | Ras (Kras or Nras) Gene MutationCanada
-
Tianjin Medical University Cancer Institute and...Not yet recruitingHER2+ Advanced Breast Cancer Patients Progressing on TKI Therapy
-
AIO-Studien-gGmbHAstraZenecaTerminatedNSCLC | Non-squamous Non-small Cell Lung Cancer Stage II | Non-squamous Non-small Cell Lung Cancer Stage IIIA | Non-squamous Non-small Cell Lung Cancer Stage IIIB | Activating EGFR MutationGermany
-
PfizerCompletedNon-Small Cell Lung CancerUnited States, Korea, Republic of, United Kingdom, Greece, Slovakia, France, Belgium, Ireland, Japan, Spain, China, Sweden, India, Hungary, Switzerland, Russian Federation, Germany, Mexico, Denmark, Austria, Finland, Poland, South Africa
-
Novartis PharmaceuticalsTerminatedNon Small Cell Lung CancerCanada, Spain, Australia, Singapore, Germany, Italy, Korea, Republic of, Norway, Taiwan, United States, France
-
Novartis PharmaceuticalsActive, not recruitingChronic Myeloid Leukemia (CML) Philadelphia Chromosome PositiveUnited States, China, Hungary, Japan, Belgium, Germany, Canada, Singapore, Australia, Israel, Netherlands, Spain, Italy, Korea, Republic of, Bulgaria, France, United Kingdom, Czechia, Sweden, India, Malaysia, Denmark, Taiwan, Norway, Fi... and more
-
First People's Hospital of HangzhouHangzhou Cancer HospitalRecruitingNon Small Cell Lung Cancer | EGFR Activating Mutation | Stage III NSCLCChina
-
Yunfei YuanCompletedHepatocellular CarcinomaChina
-
Li Xiao WeiNot yet recruitingHepatocellular Carcinoma With PVTTChina
-
Affiliated Hospital of Nantong UniversityRecruitingCML | Treatment-free Remission | FolateChina
-
Second Xiangya Hospital of Central South UniversityThe First Affiliated Hospital of Nanchang University; Xiangya Hospital of Central... and other collaboratorsRecruitingLung Cancer, Non-small Cell | Circulating Tumor DNA | EGFR Gene Mutation | EGFR-TKI Resistant Mutation | Primary ResistanceChina
-
Peking Union Medical College HospitalRecruitingCombination of Cardonizumab Injection and TKI Second Line Therapy for Advanced Hepatocellular CancerHepatocellular CarcinomaChina
-
Hunan Province Tumor HospitalRecruitingNon-small Cell Lung CancerChina
-
Hebei Medical University Fourth HospitalUnknown
-
Shanghai Chest HospitalMerck Sharp & Dohme LLCRecruiting
-
Xinqiao Hospital of ChongqingUnknownNon Small Cell Lung CancerChina
-
Zhejiang Cancer HospitalUnknownNon-small Cell Lung Cancer | Aquired Resistance | EGFR TKIsChina
-
Janssen Research & Development, LLCActive, not recruitingNon-Small-Cell Lung CancerUnited States, France, Taiwan, United Kingdom, China, Spain, Japan, Australia, Korea, Republic of, Canada
-
Fujian Cancer HospitalRecruitingStage IIIA Hepatocellular CarcinomaChina
-
AstraZenecaCompleted
-
Shouyao Holdings (Beijing) Co. LTDRecruitingNon-small-cell Lung CarcinomaChina
-
Fudan UniversityRecruiting
-
AstraZenecaCompletedLocally Advanced or Metastatic EGFR T790M+ NSCLCCanada, Korea, Republic of, Taiwan